Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Kamada

KMDA
Current price
5.17 USD -0.04 USD (-0.77%)
Last closed 5.23 USD
ISIN IL0010941198
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 310 964 096 USD
Yield for 12 month -1.90 %
1Y
3Y
5Y
10Y
15Y
KMDA
21.11.2021 - 28.11.2021

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its commercial products include KAMRAB/KEDRAB for treating prophylaxis of rabies; CYTOGAM for Prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; KAMRHO (D) IV for immune thermobocytopunic purpura; and Echis coloratus and Vipera palaestinae Antiserum for the treatment of snake bite. The company also distributes imported drug products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX for hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel. Address: 2 Holzman Street, Rehovot, Israel, 7670402

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

14 USD

P/E ratio

20.037

Dividend Yield

Current Year

+144 758 789 USD

Last Year

+129 339 000 USD

Current Quarter

+41 877 208 USD

Last Quarter

+37 736 000 USD

Current Year

+52 592 745 USD

Last Year

+46 703 000 USD

Current Quarter

+18 685 604 USD

Last Quarter

+16 751 000 USD

Key Figures KMDA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 28 432 000 USD
Operating Margin TTM 13.28 %
PE Ratio 20.037
Return On Assets TTM 3.16 %
PEG Ratio 8.75
Return On Equity TTM 7.05 %
Wall Street Target Price 14 USD
Revenue TTM 154 574 000 USD
Book Value 4.54 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 13.4 %
Dividend Yield
Gross Profit TTM 46 703 000 USD
Earnings per share 0.27 USD
Diluted Eps TTM 0.27 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 100 %
Profit Margin 9.75 %

Dividend Analytics KMDA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History KMDA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation KMDA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 20.037
Forward PE 20.5339
Enterprise Value Revenue 1.5711
Price Sales TTM 2.0117
Enterprise Value EBITDA 8.4427
Price Book MRQ 1.2382

Financials KMDA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators KMDA

For 52 weeks

4.08 USD 6.53 USD
50 Day MA 5.52 USD
Shares Short Prior Month 25 580
200 Day MA 5.6 USD
Short Ratio 0.46
Shares Short 18 678
Short Percent 0.06 %